Sensorion Hosting Key Opinion Leader Call with Dr. Michael Hoffer on Sudden Sensorineural Hearing Loss and SENS-401 as a Potential Treatment Option on July 23, 2020
(WorldNews France)

Sensorion Hosting Key Opinion Leader Call with Dr. Michael Hoffer on Sudden Sensorineural Hearing Loss and SENS-401 as a Potential Treatment Option on July 23, 2020 16 Jul 2020 07:30 CEST Company Name SENSORION ISN FR0012596468 Market Euronext Growth Symbol ALSEN Webinar to be held on Thursday, July 23, 2020 at 12:30pm Eastern Time Regulatory News: Sensorion (FR0012596468 - ALSEN) a pioneering, clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces it will host a key opinion leader (KOL) call on Sudden Sensorineural Hearing Loss and SENS-401 as a potential treatment...